Skip to search formSkip to main contentSkip to account menu

TMC 114

Known as: 114, TMC, TMC-114, TMC114 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Objective: To investigate the potential for a pharmacokinetic interaction between darunavir (DRV, TMC114, Prezista®), indinavir… 
2007
2007
The aim of the study was to predict reductions in progression to AIDS/death associated with the treatment benefit of… 
2006
2006
Darunabir, formerly TMC114, is a new protease inhibitor (PI) under clinical development designed to be active against HIV strains… 
Review
2006
Review
2006
ABSTRACT Background: Resistance to antiretroviral (ARV) drugs constitutes one of the greatest limitations to effective long-term… 
2006
2006
A major new antiretroviral has been approved, for patients resistant to more than one protease inhibitor. There is no information… 
Review
2004
Review
2004
Tibotec (formerly Tibotec-Virco) is developing TMC-114 as a potential treatment for HIV-1 infection. In February 2001, TMC-126… 
2003
2003
Gateways to clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the…